LONGITUDINAL STUDY OF OCULAR COMPLICATIONS OF AIDS
艾滋病眼部并发症的纵向研究
基本信息
- 批准号:7604151
- 负责人:
- 金额:$ 3.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2007-09-16
- 项目状态:已结题
- 来源:
- 关键词:AIDS diagnosisAcquired Immunodeficiency SyndromeCenters for Disease Control and Prevention (U.S.)CharacteristicsClinicClinic VisitsCollectionComplicationComputer Retrieval of Information on Scientific Projects DatabaseCytomegalovirusCytomegalovirus RetinitisDNADataDiseaseEnrollmentEye diseasesFundingFundusGrantHIVImmuneIncidenceInstitutionLaboratory StudyLongitudinal StudiesMedical HistoryMonitorObservational StudyOphthalmic examination and evaluationOutcomePatientsPlasma CellsQuality of lifeQuality-of-Life AssessmentRNAResearchResearch PersonnelResourcesRetinal DetachmentRiskScheduleSourceSpecimenTelephoneTestingUnited States National Institutes of HealthVisionVisitfollow-upinterestmortalityprospectivetrend
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The Longitudinal Study of Ocular Complications of AIDS is a multicenter prospective, observational study of patients with AIDS. Patients with an AIDS diagnosis according to 1993 CDC criteria, with or without ocular complications, are enrolled. Objectives are to: 1) monitor secular trends in the incidence of ocular complications of AIDS; 2) determine the effect of HAART-induced changes in immune status on the incidence and course of ocular complications of AIDS; 3) determine characteristics of patients that place them at high risk for ocular complications; and 4) evaluate effects of CMV retinitis treatments and other ocular complications on visual functions, quality of life and survival.
Approximately 2,000 patients will be enrolled in this study. Enrollment of patients with CMV retinitis at baseline will be between 300 and 600 patients. All patients will be on a 3-month follow-up schedule. Patients with a major ocular complication will have clinic follow-up visits. Patients without a major ocular complication will alternate between telephone follow-up visits and clinic follow-up visits. Data will be collected from eye examinations, fundus photographs, visual function testing, medical history, quality of life assessments, laboratory studies and plasma and blood cells collection for banking. Banked specimens will be analyzed for HIV RNA levels and CMV DNA levels. Primary interest outcomes are incidence of CMV retinitis, other ocular complications and mortality. Other outcomes of interest include incidence of extra-ocular CMV disease and complications of therapies for ocular complications, sequelae of AIDS-related eye disease ( e.g., retinal detachment), visual function, and quality of life.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目及
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
艾滋病眼部并发症的纵向研究是一项针对艾滋病患者的多中心前瞻性观察性研究。根据 1993 年 CDC 标准诊断为 AIDS 的患者,无论有或没有眼部并发症,均纳入研究。目标是: 1) 监测艾滋病眼部并发症发生率的长期趋势; 2)确定HAART引起的免疫状态变化对AIDS眼部并发症的发生率和病程的影响; 3) 确定导致眼部并发症高风险的患者特征; 4) 评估 CMV 视网膜炎治疗和其他眼部并发症对视觉功能、生活质量和生存的影响。
大约 2,000 名患者将参加这项研究。基线时患有 CMV 视网膜炎的患者入组人数将在 300 至 600 名之间。所有患者都将接受为期 3 个月的随访。患有主要眼部并发症的患者将接受临床随访。没有主要眼部并发症的患者将轮流进行电话随访和诊所随访。数据将从眼科检查、眼底照片、视功能测试、病史、生活质量评估、实验室研究以及血浆和血细胞收集中收集。将对储存的样本进行 HIV RNA 水平和 CMV DNA 水平分析。主要关注的结果是 CMV 视网膜炎的发生率、其他眼部并发症和死亡率。其他感兴趣的结果包括眼外 CMV 疾病的发生率和眼部并发症治疗的并发症、艾滋病相关眼部疾病的后遗症(例如视网膜脱离)、视功能和生活质量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MURK-HEIN HEINEMANN其他文献
MURK-HEIN HEINEMANN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MURK-HEIN HEINEMANN', 18)}}的其他基金
LONGITUDINAL STUDY OF OCULAR COMPLICATIONS OF AIDS
艾滋病眼部并发症的纵向研究
- 批准号:
7378361 - 财政年份:2006
- 资助金额:
$ 3.71万 - 项目类别:
LONGITUDINAL STUDY OF OCULAR COMPLICATIONS OF AIDS
艾滋病眼部并发症的纵向研究
- 批准号:
7200343 - 财政年份:2005
- 资助金额:
$ 3.71万 - 项目类别:
Longitudinal study of ocular complications of AIDS
艾滋病眼部并发症的纵向研究
- 批准号:
7040596 - 财政年份:2004
- 资助金额:
$ 3.71万 - 项目类别:
GANCICLOVIR CIDOFOVIR CMV RETINITIS TRIAL (GCCRT, ACTG 350)
更昔洛韦西多福韦 CMV 视网膜炎试验(GCCRT,ACTG 350)
- 批准号:
6263935 - 财政年份:1998
- 资助金额:
$ 3.71万 - 项目类别:
MONOCLONAL ANTIBODY MSL 109 CMV RETINITIS TRIAL
单克隆抗体 MSL 109 CMV 视网膜炎试验
- 批准号:
6275245 - 财政年份:1997
- 资助金额:
$ 3.71万 - 项目类别:
MONOCLONAL ANTIBODY MSL 109 CMV RETINITIS TRIAL
单克隆抗体 MSL 109 CMV 视网膜炎试验
- 批准号:
6245126 - 财政年份:1997
- 资助金额:
$ 3.71万 - 项目类别:
MONOCLONAL ANTIBODY MSL 109 CMV RETINITIS TRIAL
单克隆抗体 MSL 109 CMV 视网膜炎试验
- 批准号:
6114010 - 财政年份:
- 资助金额:
$ 3.71万 - 项目类别:
相似国自然基金
从CD4+、CD8+T细胞免疫活化分子及其上游调控因子表达探究健脾祛湿法治疗艾滋病免疫调节机制
- 批准号:81460716
- 批准年份:2014
- 资助金额:48.0 万元
- 项目类别:地区科学基金项目
HAART过程中HCV复制增强与肝细胞MAVS抗病毒通路的关系研究
- 批准号:81201286
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Hermanos de Luna y Sol: A community-based HIV prevention intervention
Hermanos de Luna y Sol:基于社区的艾滋病毒预防干预措施
- 批准号:
10626689 - 财政年份:2023
- 资助金额:
$ 3.71万 - 项目类别:
A Multimethod Assessment of the Clinical, Economic & Social Impact of the Rejection of Federal HIV Prevention Funds in Tennessee
临床、经济的多方法评估
- 批准号:
10864276 - 财政年份:2023
- 资助金额:
$ 3.71万 - 项目类别:
Harnessing big data to arrest the HIV/HCV/opioid syndemic in the rural and urban South
利用大数据遏制南方农村和城市的艾滋病毒/丙型肝炎/阿片类药物流行病
- 批准号:
10696612 - 财政年份:2023
- 资助金额:
$ 3.71万 - 项目类别:
PEARL 2.0: The impact of the Ending the HIV Epidemic initiative and risk factor interventions on the projected multimorbidity burden and healthcare costs for people aging with HIV in the United States
PEARL 2.0:“结束艾滋病毒流行”倡议和风险因素干预措施对美国艾滋病毒感染者的预计多重病负担和医疗保健费用的影响
- 批准号:
10632482 - 财政年份:2022
- 资助金额:
$ 3.71万 - 项目类别: